Staidson Beijing Biopharma (300204) - Total Liabilities

Latest as of March 2026: CN¥486.07 Million CNY ≈ $71.13 Million USD

Based on the latest financial reports, Staidson Beijing Biopharma (300204) has total liabilities worth CN¥486.07 Million CNY (≈ $71.13 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Staidson Beijing Biopharma growing its equity to track the company's year-over-year net asset growth rate.

Staidson Beijing Biopharma - Total Liabilities Trend (2007–2025)

This chart illustrates how Staidson Beijing Biopharma's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Staidson Beijing Biopharma generate to measure how efficiently the company converts operating cash flow to free cash.

Staidson Beijing Biopharma Competitors by Total Liabilities

The table below lists competitors of Staidson Beijing Biopharma ranked by their total liabilities.

Company	Country	Total Liabilities
Concentrix Corporation NASDAQ:CNXC	USA	$7.89 Billion
dentalcorp Holdings Ltd TO:DNTL	Canada	CA$1.70 Billion
Shanghai Liangxin Electrical Co Ltd SHE:002706	China	CN¥1.91 Billion
Nanjing Hanrui Cobalt Co Ltd SHE:300618	China	CN¥4.11 Billion
Kennedy-Wilson Holdings Inc NYSE:KW	USA	$5.29 Billion
Hansol Chemica KO:014680	Korea	₩405.53 Billion
Adriatic Metals Plc AU:ADT	Australia	AU$233.35 Million
Gaon Cable KO:000500	Korea	₩791.47 Billion

Liability Composition Analysis (2007–2025)

This chart breaks down Staidson Beijing Biopharma's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300204 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.00	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.60	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Staidson Beijing Biopharma's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Staidson Beijing Biopharma (2007–2025)

The table below shows the annual total liabilities of Staidson Beijing Biopharma from 2007 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥459.48 Million ≈ $67.24 Million	+97.33%
2024-12-31	CN¥232.85 Million ≈ $34.07 Million	-25.26%
2023-12-31	CN¥311.55 Million ≈ $45.59 Million	-1.24%
2022-12-31	CN¥315.45 Million ≈ $46.16 Million	+14.19%
2021-12-31	CN¥276.25 Million ≈ $40.42 Million	+2.81%
2020-12-31	CN¥268.70 Million ≈ $39.32 Million	+18.27%
2019-12-31	CN¥227.18 Million ≈ $33.24 Million	-27.72%
2018-12-31	CN¥314.30 Million ≈ $45.99 Million	-25.01%
2017-12-31	CN¥419.14 Million ≈ $61.33 Million	-3.05%
2016-12-31	CN¥432.32 Million ≈ $63.26 Million	+11.69%
2015-12-31	CN¥387.06 Million ≈ $56.64 Million	+30.09%
2014-12-31	CN¥297.54 Million ≈ $43.54 Million	+16.47%
2013-12-31	CN¥255.47 Million ≈ $37.38 Million	+32.96%
2012-12-31	CN¥192.15 Million ≈ $28.12 Million	+306.05%
2011-12-31	CN¥47.32 Million ≈ $6.92 Million	-52.03%
2010-12-31	CN¥98.66 Million ≈ $14.44 Million	+239.79%
2009-12-31	CN¥29.03 Million ≈ $4.25 Million	-0.73%
2008-12-31	CN¥29.25 Million ≈ $4.28 Million	-39.50%
2007-12-31	CN¥48.35 Million ≈ $7.07 Million	--

About Staidson Beijing Biopharma

SHE:300204 China Biotechnology

Market Cap

$1.52 Billion

CN¥10.40 Billion CNY

Market Cap Rank

#7055 Global

#1467 in China

Share Price

CN¥21.76

Change (1 day)

-0.96%

52-Week Range

CN¥19.40 - CN¥61.00

All Time High

CN¥61.00